• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[喉肌张力障碍。肉毒杆菌毒素经皮注射与经口注射的比较]

[Laryngeal dystonia. Comparison of transcutaneous and transoral injection of botulinum toxin].

作者信息

García Ruiz P J, Cenjor Español C, Sánchez Pernaute R, Astarloa R, Sánchez Bernardos V, García de Yébenes Prous J

机构信息

Servicio de Neurología, Fundación Jiménez Diaz, Madrid.

出版信息

Neurologia. 1996 Jun-Jul;11(6):216-9.

PMID:8768677
Abstract

Spasmodic dysphonia is a focal dystonia that effects the proximal muscles (adduction dystonia) or dilatory (abduction dystonia) of the larynx. Botulinum toxin (BTX), generally delivered by percutaneous injection, is the treatment of choice. Recently, use has been made of a transoral route of delivery, with BTX injected through a curved device with visual control. It remains to be determined which route is better. Percutaneous injection is simple and well-tolerated, but the transoral route is theoretically more effective. We assessed the efficacy of both techniques in 19 patients with adduction dystonia, conducting 55 treatment sessions by percutaneous injection and 20 by transoral injection. All the transoral treatments were effective (20/20, 100%), but only 81% (45-155) of the percutaneous treatments were (p < 0.05). Two patients who had doubtful responses after percutaneous delivery improved considerably when the transoral approach was used. In spite of its greater complexity, the transoral approach is probably more effective than the percutaneous route. We describe a curved device for transoral injection that is composed of simple elements available at any health center.

摘要

痉挛性发音障碍是一种局灶性肌张力障碍,影响喉部近端肌肉(内收性肌张力障碍)或扩张肌(外展性肌张力障碍)。肉毒杆菌毒素(BTX)通常通过经皮注射给药,是首选治疗方法。最近,已采用经口给药途径,通过带有视觉控制的弯曲装置注射BTX。哪种途径更好仍有待确定。经皮注射简单且耐受性良好,但经口途径理论上更有效。我们评估了这两种技术对19例内收性肌张力障碍患者的疗效,经皮注射进行了55次治疗,经口注射进行了20次治疗。所有经口治疗均有效(20/20,100%),但经皮治疗只有81%(45/55)有效(p<0.05)。两名经皮给药后反应可疑的患者采用经口方法后有明显改善。尽管经口方法更为复杂,但可能比经皮途径更有效。我们描述了一种用于经口注射的弯曲装置,它由任何健康中心都能获得的简单部件组成。

相似文献

1
[Laryngeal dystonia. Comparison of transcutaneous and transoral injection of botulinum toxin].[喉肌张力障碍。肉毒杆菌毒素经皮注射与经口注射的比较]
Neurologia. 1996 Jun-Jul;11(6):216-9.
2
Botulinum toxin treatment for spasmodic dysphonia: percutaneous versus transoral approach.肉毒杆菌毒素治疗痉挛性发音障碍:经皮注射与经口途径对比
Clin Neuropharmacol. 1998 May-Jun;21(3):196-8.
3
[Adduction spastic dysphonia: clinical and treatment].[内收型痉挛性发声障碍:临床与治疗]
Rev Clin Esp. 1998 Mar;198(3):156-8.
4
[Treatment of spasmodic dysphonia with botulinum toxin].[肉毒杆菌毒素治疗痉挛性发声障碍]
Ann Otolaryngol Chir Cervicofac. 1991;108(8):477-82; discussion 482-3.
5
[Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].[肉毒杆菌毒素。痉挛性发声障碍(喉外展肌肌张力障碍)的一种新的治疗选择]
Tidsskr Nor Laegeforen. 1993 Mar 10;113(7):841-3.
6
[The treatment of laryngeal movement disorders with botulinum toxin: part 2: experience and considerations].
HNO. 2007 Jun;55(6):485-8. doi: 10.1007/s00106-007-1554-4.
7
Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia.肉毒杆菌毒素注射治疗痉挛性发声障碍后的喉部图像分析
J Otolaryngol. 1995 Feb;24(1):64-8.
8
Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.肉毒杆菌毒素注射治疗痉挛性发声障碍:诗里拉医院的经验
J Med Assoc Thai. 2006 Dec;89(12):2077-80.
9
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia).局部注射肉毒杆菌毒素治疗局灶性喉肌张力障碍(痉挛性发声障碍)。
Laryngoscope. 1988 Feb;98(2):193-7. doi: 10.1288/00005537-198802000-00015.
10
A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report.肉毒杆菌毒素注射治疗外展性痉挛性发音障碍的方法:初步报告。
Laryngoscope. 1991 Aug;101(8):911-4. doi: 10.1288/00005537-199108000-00019.